The pharmacokinetics of metronidazole and its metabolites in critically ill patients

Journal of Antimicrobial Chemotherapy

Volumn 21, Issue 2, 1988, Pages 195-200

  Plaisance, Karen I ^a,b   Quintiliani, Richard ^a,b   Nightingale, Charles H ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; DRUG METABOLITE; METRONIDAZOLE;

1 (2 HYDROXYETHYL) 2 HYDROXYMETHYL 5 NITROIMIDAZOLE; CLINICAL ARTICLE; COMPARTMENT MODEL; CRITICAL ILLNESS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; LIVER FAILURE; PHARMACOKINETICS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CRITICAL CARE; HALF-LIFE; HUMAN; KIDNEY DISEASES; LIVER DISEASES; METRONIDAZOLE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0023950153     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/21.2.195     Document Type: Article

References (6)

1. Boxenbaum, H. G., Riegelman, S. & Elashoff, R. M. (1974). Statistical estimations in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 2, 123—48.
2. Cockcroft, D. W. & Gault, M. H. (1976). Prediction of creatinine clearance from serum creatinine. Nephron 16, 31-41.
3. Corless, J. K. & Middleton, H. M. (1983). Normal liver function: A basis for understanding hepatic disease. Archives of Internal Medicine 143, 2291-4.
4. D’Argenio, D. Z. & Schumitzky, A. (1979). A program package for simulation and parameter estimation in pharmacokinetic systems. Computer Programs in Biomedicine 9, 115—34.
5. Jensen, J. C. & Gugler, R. (1983). Single dose and multiple-dose metronidazole kinetics. Clinical Pharmacology and Therapeutics 34, 481-7.
6. Ralph, E. D. (1983). Clinical pharmacokinetics of metronidazole. Clinical Pharmacokinetics 8, 43-62.